AlphaYouAC
Insider selling
Adam Crystal sold $573K of Tango Therapeutics, Inc. (TNGX) stock
Adam Crystal, President, R&D of Tango Therapeutics, Inc. (TNGX), sold 27,000 shares of TNGX stock worth $573K, per an SEC Form 4 filed May 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 1, 2026, 4 days before it was made public.
TNGX has moved +6.4% since the trade date, from $20.98 to $22.33 (Sep 21, 2026 close).
- Traded
- May 1, 2026
- Disclosed
- May 5, 2026
- Filing delay
- 4 days
- Price since
- +6.4%
- Role
- President, R&D
- Source
- SEC Form 4
More TNGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.